chronic kidney disease (CKD).
Conditions
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: The tendency to participate in the study Having stage 2 or 3 CKD according to eGFR of 30-89 ml/min per 1.73 m2 Aged 20-80 years old
Exclusion criteria
Exclusion criteria: BMI less than 18.5 or more than 35 kg/ m2 Kidney transplant recipients Pregnancy or breastfeeding Having any kind of allergy or asthma Receiving steroids or other immune system suppressors Taking herbals in the last 3 months Smoking, Being addicted, consuming alcohol or opioids Professional athletes Having chronic inflammatory disease (rheumatoid arthritis, IBD), severe depression, schizophrenia, severe liver failure, liver cirrhosis, cancers, severe infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in kidney function ( proteinuria, 24 hour urine, serum creatinine ). Timepoint: at the beginning and end of the study. Method of measurement: 24-hour urine collection to measure 24-hour urine volume and proteinuria, Jaffe's method for measuring serum creatinine. | — |
Secondary
| Measure | Time frame |
|---|---|
| Prooxidant-antioxidant Balance. Timepoint: at the beginning and end of the study. Method of measurement: prooxidant-antioxidant Balance method.;Glycemic indices ( FBS, HbA1c, insulin ) and HOMA-IR index. Timepoint: at the beginning and end of the study. Method of measurement: biochemical assessment.;Quality of life. Timepoint: at the beginning and end of the study. Method of measurement: questionnaire.;Blood pressure. Timepoint: at the beginning and end of the study. Method of measurement: Mercury sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPaniz Anvari fard
Tabriz University of Medical Sciences
Outcome results
None listed